natgillin/translations-raw huggingface dataset:
Ask your child’ s doctor or pharmacist for advice before taking any medicine.
Posvetujte se z otrokovim zdravnikom ali farmacevtom, preden vzamete katerokoli zdravilo.
Breast-feeding Breast-feeding is not recommended during treatment with this medicine.
Dojenje Med zdravljenjem z zdravilom Diacomit dojenje ni priporočljivo.
Check with your child’ s doctor.
Posvetujte se z otrokovim zdravnikom.
HOW TO TAKE DIACOMIT
KAKO JEMATI ZDRAVILO DIACOMIT
Your child should always take these capsules exactly as your child’ s doctor has told you.
Vaš otrok mora jemati te kapsule natančno po navodilih otrokovega zdravnika.
You should check with your child’ s doctor or pharmacist if you are not sure.
Če ste negotovi, se posvetujte z zdravnikom ali s farmacevtom.
Dosage The dose is adjusted by the doctor according to your child’ s condition, generally 50 mg per kg bodyweight and per day.
Odmerjanje Odmerek zdravnik prilagodi glede na stanje vašega otroka, ponavadi 50 mg na kg telesne mase na dan.
How to take the Diacomit capsules These capsules should be swallowed whole with water.
Kako jemati zdravilo Diacomit kapsule Kapsule mora otrok pogoltniti cele z vodo.
For food and drinks to be avoided, see the section “ Taking Diacomit with food and drink” above.
Seznam živil in pijač, ki se jim je treba izogniti, je naveden v poglavju „ Jemanje zdravila Diacomit skupaj s hrano in pijačo “.
When to take Diacomit Your child should take this medicine two or three times a day at regular intervals as directed by your child’ s doctor.
Kdaj jemati zdravilo Diacomit Vaš otrok mora vzeti to zdravilo dvakrat ali trikrat dnevno v rednih časovnih presledkih po navodilih otrokovega zdravnika.
58 Dose adjustment Any increase in dose should be gradual over 3 days while the dose of the other antiepileptic medicine(s) is reduced at the same time.
58 Prilagoditev odmerka Vsako zvišanje odmerka mora biti postopno preko 3 dni, pri čemer se sočasno odmerek drugih zdravil proti epilepsiji zmanjša.
Your child’ s doctor will tell you the new dose of the other antiepileptic medicine(s).
Otrokov zdravnik vam bo povedal nove odmerke drugih zdravil proti epilepsiji.
If you have the impression that the effect of this medicine is too strong or too weak, talk to your child’ s doctor or pharmacist.
Če menite, da je učinek zdravila Diacomit premočan ali prešibak, se posvetujte z otrokovim zdravnikom ali farmacevtom.
The dose will be adjusted by the doctor according to your child’ s condition.
Odmerek bo zdravnik prilagodil glede na stanje vašega otroka.
Please consult your child’ s doctor in the event of any side effects as the doctor may have to adjust the dose of this medicine and the other antiepileptic medicine(s).
Če se pojavijo neželeni učinki, se posvetujte z otrokovim zdravnikom, saj bo morda prilagodil odmerek zdravila Diacomit in drugih zdravil proti epilepsiji.
If your child takes more Diacomit than he or she should Contact your child’ s doctor if you know or think your child has taken more medicine than he or she should have.
Če je vaš otrok vzel večji odmerek zdravila Diacomit, kot bi smel Obvestite otrokovega zdravnika, če veste ali menite, da je otrok vzel večji odmerek zdravila, kot bi smel.
If your child forgets to take Diacomit It is important that your child takes this medicine regularly at the same time each day.
Če vaš otrok pozabi vzeti zdravilo Diacomit Pomembno je, da vaš otrok jemlje to zdravilo redno, ob isti uri vsak dan.
If your child stops taking Diacomit Your child must not stop taking this medicine unless the doctor tells you to.
Če je vaš otrok prenehali jemati zdravilo Diacomit Vaš otrok ne sme prenehati jemati to zdravilo, če tega ne naroči zdravnik.
If you have any further questions on the use of this product, ask your child’ s doctor or pharmacist.
Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z otrokovim zdravnikom ali s farmacevtom.
Like all medicines, Diacomit can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo Diacomit neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Very common side effects (more than one in 10 patients): • loss of appetite, weight loss (especially when combined with the antiepileptic medicine sodium valproate); • insomnia (sleeplessness), drowsiness; • ataxia (inability to coordinate muscle movements), hypotonia (low muscle strength), dystonia (muscle disorders).
Zelo pogosti neželeni učinki (pri več kot enem od 10 bolnikov): • izguba apetita, zmanjšanje telesne mase (zlasti pri kombiniranju z natrijevim valproatom - zdravilom proti epilepsiji); • insomnia (nespečnost), zaspanost; • ataksija (nezmožnost usklajenega gibanja mišic), hipotonija (zmanjšana moč mišičja), distonija (bolezen mišičja).
Common side effects (between one in 100 patients and one in 10 patients): • raised levels of liver enzymes, especially when given with either of the antiepileptic medicines carbamazepine and sodium valproate; • aggressiveness, irritability, agitation, hyperexcitability (state of being unusually excitable); • sleep disorders (abnormal sleeping); • hyperkinesis (exaggerated movements); • nausea, vomiting; • a low number of a type of white blood cells.
Pogosti neželeni učinki (med enim od 100 bolnikov in enim od 10 bolnikov): • zvišane ravni jetrnih encimov, zlasti pri sočasnem dajanju s karbamazepinom ali natrijevim valproatom - zdraviloma proti epilepsiji; • agresivnost, razdražljivost, vznemirjenost, hiperekscitabilnost (stanje prekomernevzdražljivosti); • motnje spanja (nenormalno spanje); • hiperkinezija (čezmerni gibi); • slabost, bruhanje; • nizko število določene vrste belih krvnih celic.
Uncommon side effects (between one in 1,000 patients and one in 100 patients): • double vision when used in combination with the antiepileptic medicine carbamazepine; • sensitivity to light; • rash, skin allergy, urticaria (pinkish, itchy swellings on the skin); • fatigue (tiredness).
59 Občasni neželeni učinki (med enim od 1. 000 bolnikov in enim od 100 bolnikov): • dvojni vid, če se zdravilo Diacomit uporabi v kombinaciji s karbamazepinom (zdravilom proti epilepsiji); • občutljivost za svetlobo; • izpuščaj, kožna alergija, urtikarija (rožnata, srbeča oteklina na koži); • utrujenost.
59 To eliminate these side effects, your child’ s doctor may have to change the dose of concomitant medicines, or the dosage of Diacomit.
Otrokov zdravnik bo morda spremenil odmerke drugih zdravil ali zdravila Diacomit, da bi ti neželeni učinki izginili.
If any of these side effects persists or gets serious, or if you notice any side effects not listed in this leaflet, please tell your child’ s doctor or pharmacist.
Če katerikoli neželeni učinek ne izgine oz. postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite otrokovega zdravnika ali farmacevta.
HOW TO STORE DIACOMIT
SHRANJEVANJE ZDRAVILA DIACOMIT
• Keep out of the reach and sight of children. • Your child should not take Diacomit after the expiry date, which is stated on the label.
• Zdravilo shranjujte nedosegljivo otrokom! • Vaš otrok zdravila Diacomit ne sme uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
The expiry date refers to the last day of that month. • Store in the original package, in order to protect from light..
Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca. • Shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo.
What Diacomit 250 mg contains • The active substance is stiripentol.
Kaj vsebuje zdravilo Diacomit 250 mg • Zdravilna učinkovina je stiripentol.
Each capsule contains 250 mg of stiripentol. • The other ingredients in this medicine are povidone K29/ 32, sodium starch glycolate type A and magnesium stearate. • The capsule shell is made of gelatin, titanium dioxide (E171), erythrosine (E127), indigotin (E132).
Ena kapsula vsebuje 250 mg stiripentola. • Pomožne snovi so: povidon K29/ 32, natrijev karboksimetilškrob tipa A in magnezijev stearat. • Ovojnica kapsule je izdelana iz želatine, titanovega dioksida (E171), eritrozina (E127), indigotina (E132).
What Diacomit 500 mg contains • The active substance is stiripentol.
Kaj vsebuje zdravilo Diacomit 500 mg • Zdravilna učinkovina je stiripentol.
Each capsule contains 500 mg of stiripentol. • The other ingredients in this medicine are povidone K29/ 32, sodium starch glycolate type A and magnesium stearate. • The capsule shell is made of gelatin, titanium dioxide (E171).
Ena kapsula vsebuje 500 mg stiripentola. • Pomožne snovi so: povidon K29/ 32, natrijev karboksimetilškrob tipa A in magnezijev stearat. • Ovojnica kapsule je izdelana iz želatine in titanovega dioksida (E171).
What Diacomit 250 mg looks like and contents of the pack Diacomit 250mg capsules are pink.
Izgled zdravila Diacomit 250 mg in vsebina pakiranja Diacomit 250 g kapsule so rožnate barve.
The capsules are supplied in plastic bottles containing 30, 60 and 90 capsules in cardboard cartons.
Plastenka je vložena v kartonsko škatlo.
Diacomit is also available as 500 mg capsules for oral use and 250 mg and 500 mg powder for oral suspension in sachets.
Zdravilo Diacomit je na voljo tudi v obliki 500 mg kapsul za peroralno uporabo in 250 mg in 500 mg praška za peroralno suspenzijo v vrečkah.
What Diacomit 500 mg looks like and contents of the pack Diacomit 500mg capsules are white.
Izgled zdravila Diacomit 500 mg in vsebina pakiranja Diacomit 500 g kapsule so bele barve.
Diacomit is also available as 250 mg capsules for oral use and 250 mg and 500 mg powder for oral suspension in sachets.
Zdravilo Diacomit je na voljo tudi v obliki 250 mg kapsul za peroralno uporabo in 250 mg in 500 mg praška za peroralno suspenzijo v vrečkah.
Marketing Authorisation Holder Biocodex 7 avenue Gallieni - 94250 Gentilly - France Tel: + 33 1 41 24 30 00 - e-mail: webar@biocodex. fr
60 Imetnik dovoljenja za promet z zdravilom Biocodex 7 avenue Gallieni 94250 Gentilly Francija Tel: + 33 1 41 24 30 00 E- pošta: webar@ biocodex. fr
Manufacturer Biocodex 1 avenue Blaise Pascal - F-60000 Beauvais - France
Izdelovalec Biocodex 1 avenue Blaise Pascal F- 60000 Beauvais Francija
60 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom:
This medicine has been given “ conditional approval”.
61 Zdravilo je pridobilo tako imenovano „ pogojno dovoljenje za promet “.
This means that there is more definitive evidence to come about this medicine for the treatment of this form of epilepsy when stiripentol is used in conjunction with clobazam and valproate.
To pomeni, da se pričakujejo bolj dokončni dokazi o uporabi tega zdravila v kombinaciji s klobazamom in valproatom za zdravljenje te oblike epilepsije.
The European Medicines Agency (EMEA) will review new information on the medicine every year and this leaflet will be updated as necessary.
Evropska agencija za zdravila (EMEA) bo vsako leto ponovno pregledala nove podatke o zdravilu in posodobila navodilo za uporabo, če bo potrebno.
There are also links to other websites about rare diseases and treatments.
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA): http: // www. emea. europa. eu, kjer lahko najdete tudi povezave do drugih spletnih strani o redkih boleznih in zdravljenju.
INFORMATION FOR THE USER
62 NAVODILO ZA UPORABO
Diacomit 250 mg powder for oral suspension in sachets Stiripentol Diacomit 500 mg powder for oral suspension in sachets Stiripentol
Diacomit 500 mg prašek za peroralno suspenzijo v vrečkah stiripentol
Your child must NOT take Diacomit • if your child is allergic (hypersensitive) to stiripentol or to any of the other ingredients of Diacomit. • if your child has ever experienced attacks of delirium.
Vaš otrok NE sme jemati zdravila Diacomit • če je vaš otrok preobčutljiv za (alergičen na) stiripentol ali katerokoli sestavino zdravila Diacomit, • če je vaš otrok kdaj imel napade delirija.
• if your child uses one of the following products:
63 • Če vaš otrok jemlje kateregakoli od naslednjih zdravil:
- antiepileptic medicines containing:
- Zdravila proti epilepsiji, ki vsebujejo:
62 phenobarbital, primidone, phenytoin, carbamazepine, diazepam.
fenobarbital, primidon, fenitoin, karbamazepin, diazepam.
caffeine or theophylline (these substances help restore mental alertness).
- kofein in teofilin (te snovi pripomorejo k vzpostavitvi mentalne budnosti).
The combination with Diacomit should be avoided as it may increase their blood levels, leading to digestive disorders, racing heart and insomnia.
zdravilom Diacomit se je treba izogibati, saj lahko pride do zvišanja njunih koncentracij v krvi, kar povzroči prebavne težave, hitro bitje srca in nespečnost.
If your child has problems with certain ingredients of Diacomit (e. g. aspartame, glucose, sorbitol).
Če ima vaš otrok težave z določenimi sestavinami zdravila Diacomit (npr. aspartam, glukoza, sorbitol).
In this case, please see below: “ Important information about some of the ingredients of Diacomit”.
„ Pomembne informacije o nekaterih sestavinah zdravila Diacomit “.
Important information about some of the ingredients of Diacomit Contains a source of phenylalanine.
Pomembne informacije o nekaterih sestavinah zdravila Diacomit To zdravilo vsebuje vir fenilalanina.
Your child should always take the contents of each sachet exactly as your child’ s doctor has told you.
Vaš otrok mora vzeti vsebino vrečke natančno po navodilih otrokovega zdravnika.
63 How to take the Diacomit powder for oral suspension The powder should be mixed in a glass of water and should be taken immediately after mixing during the meal.
64 Kako jemati prašek za peroralno suspenzijo Diacomit Prašek zmešajte v kozarcu vode in vsebino popijte takoj po pripravi, med obrokom.
Dose adjustment Any increase in dose should be gradual over 3 days while the dose of the other antiepileptic medicine(s) is reduced at the same time.
Prilagoditev odmerka Vsako zvišanje odmerka mora biti postopno preko 3 dni, pri čemer se sočasno odmerek drugih zdravil proti epilepsiji zmanjša.
Common side effects (between one in 100 patients and one in 10 patients): • raised levels of liver enzymes, especially when given with either of the antiepileptic medicines carbamazepine and sodium valproate; • aggressiveness, irritability, agitation, hyperexcitability (state of being unusually excitable); • sleep disorders (abnormal sleeping);
Pogosti neželeni učinki (med enim od 100 bolnikov in enim od 10 bolnikov): • zvišane ravni jetrnih encimov, zlasti pri sočasnem dajanju s karbamazepinom ali natrijevim valproatom - zdraviloma proti epilepsiji; 65 • agresivnost, razdražljivost, vznemirjenost, hiperekscitabilnost (stanje prekomernevzdražljivosti); • motnje spanja (nenormalno spanje); • hiperkinezija (čezmerni gibi); • slabost, bruhanje; • nizko število določene vrste belih krvnih celic.
Uncommon side effects (between one in 1,000 patients and one in 100 patients): • double vision when used in combination with the antiepileptic medicine carbamazepine; • sensitivity to light; • rash, skin allergy, urticaria (pinkish, itchy swellings on the skin); • fatigue (tiredness).
Občasni neželeni učinki (med enim od 1. 000 bolnikov in enim od 100 bolnikov): • dvojni vid, če se zdravilo Diacomit uporabi v kombinaciji s karbamazepinom (zdravilom proti epilepsiji); • občutljivost za svetlobo; • izpuščaj, kožna alergija, urtikarija (rožnata, srbeča oteklina na koži); • utrujenost.
To eliminate these side effects, your child’ s doctor may have to change the dose of concomitant medicines, or the dosage of Diacomit.
Otrokov zdravnik bo morda spremenil odmerke drugih zdravil ali zdravila Diacomit, da bi ti neželeni učinki izginili.
Each sachet contains 250 mg of stiripentol. • The other ingredients in this medicine are povidone K29/ 32, sodium starch glycolate type A, glucose liquid (spray dried), erythrosine (E127), titanium dioxide (E171), aspartame (E951), tutti frutti flavour (contains sorbitol), carmellose sodium, hydroxyethylcellulose.
Ena vrečka vsebuje 250 mg stiripentola. • Pomožne snovi so: povidon K29/ 32, natrijev karboksimetilškrob tipa A, tekoča glukoza (ki je posušena z razprševanjem tekočine), eritrozin (E127), titanov dioksid (E171), aspartam (E951), aroma tutti frutti (vsebuje sorbitol), natrijev karmelozat, hidroksietilceluloza.
Each sachet contains 500 mg of stiripentol. • The other ingredients in this medicine are povidone K29/ 32, sodium starch glycolate type A, glucose liquid (spray dried), erythrosine (E127), titanium dioxide (E171), aspartame (E951), tutti frutti flavour (contains sorbitol), carmellose sodium, hydroxyethylcellulose.
Ena vrečka vsebuje 500 mg stiripentola. • Pomožne snovi so: povidon K29/ 32, natrijev karboksimetilškrob tipa A, tekoča glukoza (ki je posušena z razprševanjem tekočine), eritrozin (E127), titanov dioksid (E171), aspartam (E951), aroma tutti frutti (vsebuje sorbitol), natrijev karmelozat, hidroksietilceluloza.
What Diacomit 250 mg looks like and contents of the pack This medicine is a pale pink powder supplied in sachets.
Izgled zdravila Diacomit 250 mg in vsebina pakiranja Zdravilo je bledo rožnat prašek in je pakirano v vrečkah.
Cartons contain either 30, 60, or 90 sachets.
Škatle vsebujejo 30, 60 ali 90 vrečk.
Diacomit is also available as 250 mg and 500 mg capsules for oral use and 500 mg powder for oral suspension in sachets.
Zdravilo Diacomit je na voljo tudi v obliki 250 mg in 500 mg kapsul za peroralno uporabo in 500 mg prašku za peroralno suspenzijo v vrečkah.
What Diacomit 500 mg looks like and contents of the pack This medicine is a pale pink powder supplied in sachets.
Izgled zdravila Diacomit 500 mg in vsebina pakiranja Zdravilo je bledo rožnat prašek in je pakirano v vrečkah.
Diacomit is also available as 250 mg and 500 mg capsules for oral use and 250 mg powder for oral suspension in sachets.
66 Zdravilo Diacomit je na voljo tudi v obliki 250 mg in 500 mg kapsul za peroralno uporabo in 250 mg prašku za peroralno suspenzijo v vrečkah.
Marketing Authorisation Holder Biocodex 7 avenue Gallieni - 94250 Gentilly - France Tel: + 33 1 41 24 30 00 - e-mail: webar@biocodex. fr
Imetnik dovoljenja za promet z zdravilom Biocodex 7 avenue Gallieni 94250 Gentilly Francija Tel: + 33 1 41 24 30 00 E- pošta: webar@ biocodex. fr
65 Manufacturer Biocodex 1 avenue Blaise Pascal - F-60000 Beauvais - France
Izdelovalec Biocodex 1 avenue Blaise Pascal F- 60000 Beauvais Francija
This leaflet was last approved in
67 Navodilo je bilo odobreno
This medicine has been given “ conditional approval”.
Zdravilo je pridobilo tako imenovano „ pogojno dovoljenje za promet “.
66
68
Ref.
London, 21. avgust 2008 Sklic dok.
It was to be available as a gel containing 22.9 mg of ketoprofen per gram of gel.
Zdravilo je na voljo v obliki gela, ki vsebuje 22, 9 mg ketoprofena na gram gela.
In Diractin gel, the ketoprofen is contained in special, small, fatty particles (called ‘ Transfersomes’) that are expected to carry the ketoprofen through the skin and release it deep below the skin, where the inflammation in osteoarthritis occurs.
Ketoprofen se v gelu Diractin nahaja v posebnih, majhnih, maščobnih delcih (imenovanih transfersomi), za katere se pričakuje, da bodo prenesli ketoprofen skozi kožo in ga sprostili globoko pod kožo, kjer se pri osteoartritisu pojavi vnetje.
Following the CHMP’ s opinion, it usually takes around two months for the European Commission to grant a license.
Potem ko CHMP izda svoje mnenje, navadno traja približno dva meseca, preden Evropska komisija dovoljenje odobri.
Reproduction is authorised provided the source is acknowledged. could not have been approved for the treatment of the symptoms of inflammation and pain associated with osteoarthritis.
Kakšno je bilo takrat priporočilo CHMP?
Docetaxel Winthrop is a concentrate and solvent to be made up into a solution for infusion (drip into a vein).
Zdravilo Docetaxel Winthrop obsega koncentrat in vehikel za pripravo raztopine za infundiranje (infuzijo v veno).
This medicine is the same as TAXOTERE, which is already authorised in the European Union.
To zdravilo je enako zdravilu TAXOTERE, ki je že odobreno v Evropski uniji.
The company that makes TAXOTERE has agreed that its scientific data can be used for Docetaxel Winthrop.
Podjetje, ki proizvaja zdravilo TAXOTERE, je dovolilo, da se lahko znanstveni podatki tega zdravila uporabijo tudi za zdravilo Docetaxel Winthrop.
Docetaxel Winthrop is an anticancer medicine.
Docetaxel Winthrop je zdravilo proti raku.
It is used in: • breast cancer.
Uporablja se pri: • raku dojke.
It can be used on its own after other treatments have failed.
Uporablja se lahko kot monoterapija po neuspešnih drugih oblikah zdravljenja.
It can also be used with other anticancer medicines (doxorubicin, cyclophosphamide, trastuzumab or capecitabine) in patients who have not yet received any treatment for their cancer or after other treatments have failed, depending on the type and stage of the breast cancer being treated. • non-small cell lung cancer.
Prav tako se lahko uporablja z drugimi zdravili proti raku (doksorubicinom, ciklofosfamidom, transtuzumabom ali kapecitabinom) pri bolnikih, ki proti raku še niso prejemali drugih zdravil ali pri katerih so bile druge oblike zdravljenja neuspešne, odvisno od vrste in stadija raka dojke, ki se zdravi. • nedrobnoceličnem pljučnem raku.
It can also be used with cisplatin (another anticancer medicine) in patients who have not yet received any treatment for their cancer. • prostate cancer, when the cancer does not respond to hormonal treatment.
Uporablja se lahko tudi s cisplatinom (drugim zdravilom proti raku) pri bolnikih, ki se še niso zdravili proti raku. • raku prostate, kadar se rak ne odziva na hormonsko zdravljenje.
It is used with prednisone or prednisolone (anti-inflammatory medicines). • gastric adenocarcinoma (a type of stomach cancer) in patients who have not yet received any treatment for their cancer.
Uporablja se s prednizonom ali prednizolonom (protivnetnima zdraviloma). • adenokarcinomu želodca (vrsta želodčnega raka) pri bolnikih, ki se še niso zdravili proti raku.
It is used with cisplatin and 5-fluorouracil (other anticancer medicines). • head and neck cancer in patients whose cancer is advanced.
Uporablja se s cisplatinom in 5- fluoroacilom (drugima zdraviloma proti raku). • raku glave in vratu pri bolnikih, pri katerih je rak napredoval.
It is used with cisplatin and 5-fluorouracil.
Uporablja se s cisplatinom in 5 - fluoroacilom.
See the Summary of Product Characteristics, also part of the EPAR, for full details.
Podrobne informacije so na voljo v Povzetku glavnih značilnosti zdravila, ki je prav tako del poročila EPAR.
Docetaxel Winthrop should be used in specialised chemotherapy wards and it should only be given under the supervision of a doctor who is qualified in the use of anticancer chemotherapy.
Zdravilo Docetaxel Winthrop je treba uporabljati na specializiranih oddelkih za kemoterapijo in se sme dajati le pod nadzorom zdravnika, izkušenega na področju uporabe kemoterapije proti raku.
Docetaxel Winthrop is only used when the neutrophil count (a type of white blood cell) is at least 1,500 cells/ mm3.
Zdravilo Docetaxel Winthrop se uporablja le, kadar je število nevtrofilcev (vrste belih krvnih celic) vsaj 1500 celic/ mm3.
Treatment with dexamethasone (an anti-inflammatory medicine) should be given to the patient on the day before treatment (for prostate cancer) or the day before and the two days after treatment (for other types of cancers).
Dan pred zdravljenjem (za rak prostate) ali dan pred zdravljenjem in dva dni po njem (za druge vrste rakov) je treba bolniku dajati deksametazon (protivnetno zdravilo).
Docetaxel Winthrop is given as a one-hour infusion every three
Zdravilo Docetaxel Winthrop se daje v obliki enourne infuzije vsake tri tedne.
For more information, see the Summary of Product Characteristics.
(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Kako zdravilo Docetaxel Winthrop deluje?